Skip to content

Opening book details…

Can I read The effect of nirmatrelvir‐ritonavir on viral clearance and length of hospital stay in patients infected with SARS‐CoV‐2 omicron variants on EtoBox?

The effect of nirmatrelvir‐ritonavir on viral clearance and length of hospital stay in patients infected with SARS‐CoV‐2 omicron variants by Yu Wang; Danyang Zhao; Xubo Chen; Xinbing Liu; Wenying Xiao; Liuliu Feng is a Medicine article available to read on EtoBox.

What is The effect of nirmatrelvir‐ritonavir on viral clearance and length of hospital stay in patients infected with SARS‐CoV‐2 omicron variants about?

Background: The pandemic of coronavirus disease 2019 (COVID-19) has caused heavy burdens on national healthcare systems. Nirmatrelvir-ritonavir (Paxlovid) may be one of the most promising therapeutic drugs, with reports of up to 89% reduction rates in hospitalization risk and death among patients with mild-to-moderate COVID-19 who are at risk of developing severe disease. However, limited studies have investigated the effects of this class of drugs on viral clearance and length of hospital stay.Methods: In this study, we retrospectively analyzed the characteristics of patients infected with the Omicron variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and investigated the effects of oral nirmatrelvir-ritonavir on viral clearance and length of hospital stay in mild-to-moderate COVID-19 patients at high risk for progression to severe disease. Results: The median SARS-CoV-2 negative conversion time was 16 (13-20) versus 13 (10-16) days (control group versus nirmatrelvir-ritonavir group, p < 0.001), the median length of hospital stay was 13 (10-16) versus 12 (13-14) days (control group versus nirmatrelvir-ritonavir group, p = 0.01), and the SARS-CoV-2 negative con

Who reads The effect of nirmatrelvir‐ritonavir on viral clearance and length of hospital stay in patients infected with SARS‐CoV‐2 omicron variants?

It is typically read by researchers, students, and practitioners in Medicine.

Author
Yu Wang; Danyang Zhao; Xubo Chen; Xinbing Liu; Wenying Xiao; Liuliu Feng
Publisher
Wiley
Published
2023
Language
EN
Field
Medicine (Health Sciences)

More by Yu Wang; Danyang Zhao; Xubo Chen; Xinbing Liu; Wenying Xiao; Liuliu Feng

Browse all works by Yu Wang; Danyang Zhao; Xubo Chen; Xinbing Liu; Wenying Xiao; Liuliu Feng